Previous Article | Next Article ![]()
Journal of Bacteriology, November 1999, p. 6806-6813, Vol. 181, No. 21
1 Department of Medicinal
Chemistry and 2Institute for Structural Biology
and Drug Discovery, Virginia Commonwealth
University, Richmond, Virginia 23219
Received 10 June 1999/Accepted 24 August 1999
The ccr gene, encoding crotonyl coenzyme A (CoA)
reductase (CCR), was cloned from Streptomyces cinnamonensis
C730.1 and shown to encode a protein with 90% amino acid sequence
identity to the CCRs of Streptomyces collinus and
Streptomyces coelicolor. A ccr-disrupted mutant, S. cinnamonensis L1, was constructed by inserting
the hyg resistance gene into a unique BglII
site within the ccr coding region. By use of the
ermE* promoter, the S. collinus ccr gene was
expressed from plasmids in S. cinnamonensis C730.1/pHL18
and L1/pHL18. CCR activity in mutant L1 was shown to decrease by more than 90% in both yeast extract-malt extract (YEME) medium and a
complex fermentation medium, compared to that in wild-type C730.1. Compared to C730.1, mutants C730.1/pHL18 and L1/pHL18 exhibited a huge
increase in CCR activity (14- and 13-fold, respectively) in YEME medium
and a moderate increase (3.7- and 2.7-fold, respectively) in the
complex fermentation medium. In the complex fermentation medium,
S. cinnamonensis L1 produced monensins A and B in a ratio of 12:88, dramatically lower than the 50:50 ratio observed for both
C730.1 and C730.1/pHL18. Plasmid (pHL18)-based expression of the
S. collinus ccr gene in mutant L1 increased the monensin A/monensin B ratio to 42:58. Labeling experiments with
[1,2-13C2]acetate demonstrated the same
levels of intact incorporation of this material into the
butyrate-derived portion of monensin A in both C730.1 and mutant
C730.1/pLH18 but a markedly decreased level of such incorporation in
mutant L1. The addition of crotonic acid at 15 mM led to significant
increases in the monensin A/monensin B ratio in C730.1 and C730.1/pHL18
but had no effect in S. cinnamonensis L1. These results
demonstrate that CCR plays a significant role in providing butyryl-CoA
for monensin A biosynthesis and is present in wild-type S. cinnamonensis C730.1 at a level sufficient that the availability
of the appropriate substrate (crotonyl-CoA) is limiting.
Polyketide synthases (PKSs) produce
natural products such as erythromycin, pikromycin, and rifamycin by
catalyzing successive decarboxylative condensations with malonyl
coenzyme A (CoA) and methylmalonyl-CoA and an appropriate starter unit
(2, 22, 28). Malonyl-CoA is likely derived from the
carboxylation of acetyl-CoA, while a variety of different pathways give
rise to methylmalonyl-CoA (18, 24). A number of
streptomycete PKSs, such as those involved in monensin, FK520, tylosin,
and niddamycin production, also use ethylmalonyl-CoA at a specific
stage in polyketide chain assembly (6, 8, 14, 18).
Ethylmalonyl-CoA is likely derived from the carboxylation of
butyryl-CoA. For monensin and FK520, either methylmalonyl-CoA or
ethylmalonyl-CoA can be used at the same stage in elongation,
presumably reflecting a relaxed substrate specificity for the
corresponding acyltransferase domain of the PKS (3, 6,
9). Thus, fermentations of Streptomyces cinnamonensis
produce a mixture of monensins A and B (Fig.
1) in a ratio presumably dependent upon
the relative concentrations of ethylmalonyl-CoA and methylmalonyl-CoA.
Genetic manipulation of the pathways that play an important role in
butyryl-CoA production should significantly alter the monensin
A/monensin B ratio.
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of Crotonyl Coenzyme A Reductase in Determining the
Ratio of Polyketides Monensin A and Monensin B Produced by
Streptomyces cinnamonensis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (23K):
[in a new window]
FIG. 1.
Role of CCR in providing a butyryl-CoA precursor for
monensin A biosynthesis.
Stable isotope incorporation experiments have indicated the presence of at least two pathways for butyryl-CoA production in streptomycetes. One pathway involves isomerization of the valine catabolite isobutyryl-CoA to form butyryl-CoA and is catalyzed by coenzyme B12-dependent isobutyryl-CoA mutase (ICM) (18, 29). The second pathway involves the condensation of two acetate units and is thought to culminate in the reduction of crotonyl-CoA to butyryl-CoA, catalyzed by crotonyl-CoA reductase (CCR) (25). This enzyme was first purified from Streptomyces collinus, and the corresponding gene, ccr, was shown to be located within a set of primary metabolic genes involved in acetate assimilation in S. collinus (25). A similar set of genes was recently identified from sequencing of the Streptomyces coelicolor chromosome (Fig. 2). Subsequently, ccr homologs were observed within the biosynthetic gene clusters of tylosin, niddamycin, and coronafacic acid, all natural products made with an ethylmalonyl-CoA precursor (8, 17, 22). Despite these observations, the role of these homologs or ccr itself in providing butyryl-CoA for polyketide biosynthesis by the corresponding producing organisms has yet to be established.
|
In the current study, S. cinnamonensis ccr has been cloned, sequenced, and shown to be located within a conserved set of primary metabolic genes. This gene, rather than any putative ccr homologs located within the monensin PKS gene cluster, is primarily responsible for CCR activity in S. cinnamonensis and has a significant role in producing butyryl-CoA for monensin A biosynthesis. Heterologous expression of S. collinus ccr in S. cinnamonensis produces increased levels of CCR but does not change the monensin A/monensin B ratio. This latter observation contrasts the recent observation that heterologous expression of the S. collinus ccr gene is necessary for the production of 6-desmethyl-6-ethylerythromycin in a Saccharopolyspora erythraea strain expressing a hybrid PKS which contains a methylmalonyl-CoA-ethylmalonyl-CoA acyltransferase switch (22).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains, plasmids, and culture conditions.
Bacterial strains and plasmids used in this study are listed in Table
1. S. cinnamonensis C703.1 was
kindly provided by Eli Lilly & Company. Escherichia coli
XL1-Blue and ET12567 were grown at 37°C in Luria-Bertani medium
supplemented with either ampicillin (100 µg/ml) or apramycin (50 µg/ml) when necessary (20). Cultures of S. cinnamonensis and Streptomyces lividans were grown in
YEME medium (13) at 30°C for isolation of genomic and
plasmid DNAs, preparation of protoplasts, CCR enzyme assay, and fatty
acid analysis. R2YE medium (13) was used for
preparation of Streptomyces spore suspensions and for
regeneration of protoplasts after transformations.
|
DNA isolation, amplification, and manipulation. Streptomyces genomic DNA was prepared following standard protocols (13). Alkaline lysis was used to isolate plasmid DNA from Streptomyces strains (13). E. coli plasmid DNA was prepared with a Sigma P-MINI kit. Oligonucleotides for PCR were obtained from Gibco BRL (Gaithersburg, Md.). PCR amplifications were carried out with a GeneAmp 2400 PCR system from Perkin-Elmer (Branchburg, N.J.). General DNA manipulations were performed following standard protocols (20).
Hybridizations.
For Southern hybridization, genomic DNA from
S. cinnamonensis C730.1 was completely digested with a range
of restriction endonucleases. The fragments, after separation by
agarose gel electrophoresis, were transferred to nylon membranes
(20). For colony hybridization, E. coli colonies
were replica transferred to nylon membranes. The cells were then lysed,
and the DNA was denatured, neutralized, and immobilized
(20). The radiolabeled probe was prepared with [
-32P]dCTP (3,000 Ci/mmol; Amersham), a random-primer
labeling kit from Strategene (La Jolla, Calif.), and a 1.4-kb S. collinus ccr gene fragment from pZYB3 (25). Conditions
for prehybridization and hybridization were slightly modified from
standard protocols (20), with final washes for Southern
hybridization and colony hybridization being carried out at 30°C in
1× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and at
65°C in 0.5× SSC, respectively.
Nucleotide sequence analysis. Fragments of S. cinnamonensis genomic DNA containing ccr were subcloned into pUC119, and the corresponding plasmids were recovered from E. coli XL1-Blue. DNA sequencing was carried out at the Biopolymer Laboratory at the University of Maryland, Baltimore. Sequence data were analyzed with MacVector software (version 6.01; Oxford Molecular Ltd.). The nucleotide and deduced amino acid sequences were compared with those in public sequence databases by use of the BLAST family of programs (1).
Transformations. Preparation and transformation of competent E. coli cells were performed by standard methods (20). Streptomyces protoplasts were transformed in the presence of 25% polyethylene glycol (13). To transform S. cinnamonensis, plasmid DNA prepared from S. lividans 1326 or E. coli ET12567 was used.
Insertional inactivation of S. cinnamonensis ccr. A shuttle vector (pKC1139) containing the temperature-sensitive Streptomyces origin of replication from pSG5 was used to construct ccr gene disruption plasmids (5). A 1.7-kb BglII hyg (hygromycin resistance) gene fragment was excised from a pIJ963 (15) derivative in which the BamHI site had been destroyed. This hyg gene fragment was inserted in the coding region of S. cinnamonensis ccr. The primers used for PCR identification of the double-crossover mutant were CCR1 (5'-AAGCAGGGCGACAACGTTCGGATCC-3') and CCR2 (5'-GATGTCGATCGGGATCCACTTGGGG-3').
Enzyme assay for CCR. The CCR activity of the S. cinnamonensis cultures grown in either YEME medium or the production medium (described below) was analyzed as previously described (25).
Fatty acid analysis. S. cinnamonensis cultures were grown in YEME medium at 30°C and 300 rpm for 24 h, and the fatty acids were extracted and analyzed as described previously (27).
Production and quantitation of monensins A and B. A two-stage fermentation process was used for monensin production. In the first stage, S. cinnamonensis spore suspensions were inoculated into a seed medium consisting of glucose (2.5%), soybean meal (1.5%), CaCO3 (0.3%), FeSO4 · 7H2O (0.03%), and MnCl2 · 4H2O (0.003%); incubations were carried out at 30°C and 300 rpm for 30 h. In the second stage, a 5% inoculum of the seed cultures was transferred to a production medium, which was the same as the seed medium but which contained 5% glucose. Fermentations were carried out at 30°C and 300 rpm for 6 days. For feeding studies with either crotonic acid or butyric acid, the compounds were added as stock solutions of 1 M and pH 7.0 in equal portions at 48, 60, and 72 h during fermentation to final concentrations of 15 mM. Monensins A and B were isolated from the whole broth by the standard method (18), which involves homogenization with methanol and extraction with chloroform. The crude extracts containing the antibiotics were finally dissolved in methanol and analyzed by high-pressure liquid chromatography (HPLC) with a C18 column and a refractive index detector (3). The mobile phase used in HPLC analysis was composed of methanol and water (90:10). Monensin A/monensin B ratios were determined as the ratios of the corresponding peak areas. Total monensin titers were quantified by comparison of the sum of monensin A and B peak areas against the standard curve obtained with the commercial monensin A product from Sigma.
Isotope labeling experiments with [1,2-13C2]acetate. Conditions for the production and preliminary extraction of monensins A and B used in these studies were identical to those described above. A 1:3 mixture of [1,2-13C2]acetate and unlabeled acetate was prepared at neutral pH and added batchwise at 48, 60, and 72 h during the production phase of S. cinnamonensis fermentations to a final concentration of 30 mM. Monensin A was purified from organic extracts of fermentations of S. cinnamonensis C730.1 (400 ml), C730.1/pHL18 (400 ml), and S. cinnamonensis L1 (600 ml) following standard procedures (18). The 13C {1H} NMR spectra of monensin A purified from each fermentation were recorded on a 300-MHz spectrometer.
Nucleotide sequence accession number. The sequence of S. cinnamonensis ccr and the meaA fragment reported here has been deposited in the GenBank database under accession no. AF178673.
| |
RESULTS |
|---|
|
|
|---|
Cloning and sequence analysis of S. cinnamonensis ccr. Southern analysis with a 1.4-kb NdeI-BamH fragment of pZYB3 (containing the entire S. collinus ccr gene) as a probe revealed a single 5.7-kb hybridizing fragment from a PstI digest of S. cinnamonensis C730.1 genomic DNA. A 3.0-kb region of this fragment was sequenced and shown to contain one complete (encoding 453 amino acids) and two incomplete (encoding 167 and 228 amino acids) open reading frames (ORFs), all transcribed in the same direction (Fig. 2). Sequence analysis showed that the complete ORF designated ccr encodes a CCR with the highest predicted amino acid sequence identity (90%) and similarity (93%) to the CCR of S. collinus (25) and the putative CCR of S. coelicolor (GenBank accession no. AL035161). S. cinnamonensis ccr has an meaA gene (encoding a putative coenzyme B12-dependent mutase) (12) located downstream and a tcmR-homologous gene (encoding a putative transcriptional regulator) (10) located upstream (Fig. 2). Sequencing data available to date are consistent with this organization of genes in S. collinus and S. coelicolor (12). The requirement of ccr and meaA for efficient growth of S. collinus on acetate has also been established (12).
Targeted disruption of S. cinnamonensis ccr. An insertional inactivation strategy was used to disrupt S. cinnamonensis ccr. A 2.7-kb NcoI-XbaI DNA segment was removed from pHL1 (a pUC119 derivative carrying the cloned 5.7-kb PstI S. cinnamonensis ccr gene fragment), and the resulting linearized plasmid was blunt ended and religated to yield pHL7. To construct pHL9, the 1.7-kb BglII hyg gene fragment described in Materials and Methods was inserted into a unique BglII site within the ccr coding region of pHL7. The orientation of this fragment in pHL9 is such that both hyg and ccr are transcribed in the same direction. The 4.7-kb BamHI-HindIII ccr::hyg fragment was excised from pHL9 and subcloned into pKC1139 to generate pHL19 (Fig. 3). S. cinnamonensis protoplasts were transformed with pHL19 isolated from E. coli ET12567, and colonies resistant to both hygromycin and apramycin (Hmr Amr) were obtained. Mutants in which a single crossover between pHL19 and the S. cinnamonensis chromosome had occurred were selected by cultivating one of the Hmr Amr transformants at 39°C in the presence of the two antibiotics. The genotype of one such single-crossover mutant was confirmed by PCR. Following three rounds of propagation of this single-crossover mutant in the absence of any antibiotics at 30°C, colonies resistant to only hygromycin (Hmr Ams) were obtained. One such colony, designated L1, was confirmed as the desired ccr-disrupted mutant by both PCR analysis (Fig. 3) and a CCR enzyme assay (see below).
|
Expression of the S. collinus ccr gene in S. cinnamonensis C730.1 and L1. The S. collinus ccr gene was excised as a 1.9-kb XbaI-HindIII fragment from pZYB3 (25) and subcloned into pSE34 (Table 1) to produce pHL18. In pHL18, ccr is expressed from the strong constitutive ermE* promoter (4). pHL18 was introduced into S. lividans 1326. Plasmid DNA isolated from S. lividans transformants was used to transform S. cinnamonensis C730.1 and L1, generating the ccr-overexpressing mutant C730.1/pHL18 and the complementation mutant L1/pHL18. The overproduction of CCR in these mutants was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis (data not shown) and by a CCR enzyme assay (see below).
CCR activity in S. cinnamonensis cell extracts.
The effects of disruption of the chromosomal ccr gene and
plasmid-based expression of ccr on CCR activity in S. cinnamonensis were evaluated with cell extracts. This analysis
revealed that cloned ccr was responsible for the majority of
the CCR activity under two different growth conditions and that
significant increases in CCR activity in either S. cinnamonensis strain (C730.1 and L1) could be accomplished by
plasmid-based expression of S. collinus ccr. In YEME medium,
CCR activity in S. cinnamonensis C730.1 (wild type) was
fivefold higher than that previously reported for cell extracts of
S. collinus (Table 2)
(25). Only 5% of this activity could be detected in cell
extracts of S. cinnamonensis L1, while 14- and 13-fold
increases in CCR activity were observed for S. cinnamonensis
C730.1/pHL18 and L1/pHL18, respectively. In the complex fermentation
medium used for monensin production, the levels of CCR activity in
S. cinnamonensis C730.1 were 2.5- to 4.4-fold higher
than even the levels observed for the same strain grown in YEME medium.
At day 5 of fermentation, the levels of CCR activity were 60% higher
than the levels of CCR activity obtained by expression of S. collinus ccr from the ermE* promoter in S. erythraea (22). CCR activity in S. cinnamonensis L1 grown in the same complex fermentation medium was
again 90 to 95% lower than that observed with strain C730.1. The
highest levels of CCR activity were observed for C730.1/pHL18 and
L1/pHL18 grown in complex fermentation medium. The activities were 3.7- and 2.7-fold higher than those observed for C730.1 grown under the same
conditions.
|
Effect of CCR on monensin A/monensin B ratios. The role of CCR in producing butyryl-CoA for monensin A biosynthesis was investigated by analyzing the relative amounts of monensins A and B made by the different S. cinnamonensis strains. It was predicted that any significant changes in the amount of butyryl-CoA formed in S. cinnamonensis as a result of changes in the levels of CCR activity would be reflected in this ratio. In the complex fermentation medium, S. cinnamonensis C730.1 produced almost equal amounts of monensins A and B (Table 2 and Fig. 4). No significant change in this ratio was seen when the CCR expression plasmid was introduced into this strain. In contrast, the ccr-disrupted mutant (S. cinnamonensis L1) produced predominantly monensin B, with monensin A representing less than 15% of the total monensins. This monensin A/monensin B ratio returned to almost that observed in the wild type when the CCR expression plasmid was introduced into this mutant (Table 2). In these experiments, disruption and/or overexpression of ccr caused no more than 20% changes in the amounts of total monensins.
|
Incorporation of [1,2-13C2]acetate into
monensin A.
The decreased monensin A/monensin B ratio observed in
fermentations of S. cinnamonensis L1 clearly suggests a
significant role of CCR in producing a butyryl-CoA precursor for
monensin A biosynthesis. A decrease in the labeling of the
butyrate-derived positions of monensin A by labeled acetyl-CoA would
also be expected because crotonyl-CoA, the substrate for CCR, is
thought to be derived from acetyl-CoA via a reversal of the fatty acid
-oxidation pathway (25). This prediction was confirmed by
carrying out monensin A [1,2-13C2]acetate
incorporation experiments with S. cinnamonensis C730.1, L1,
and C730.1/pHL18. In S. cinnamonensis C730.1,
approximately 0.8% ± 0.2% of the acetate-derived positions of
monensin A were labeled intact by the dually labeled acetate (Table 2
and Fig. 5). Labeling of 0.4% ± 0.1%
of the butyrate-derived position of monensin A (C15, C16, C32, C33) was
observed in this experiment. Thus, under the fermentation conditions
used, approximately 50% of the butyrate-derived position of monensin A
is derived from the acetate pool in S. cinnamonensis. Very
similar labeling of the acetate- and butyrate-derived positions was
seen with S. cinnamonensis C730.1/pHL18. This result is
entirely consistent with the observation that the increased levels of
CCR activity in this strain do not increase the monensin A/monensin B
ratio (Table 2). In S. cinnamonensis L1, similar levels of
labeling of the acetate-derived positions of monensin A were observed.
However, in this experiment, only low-level (approximately 0.1%)
intact labeling of the butyrate-derived position by dually labeled
acetate was observed (Table 2 and Fig. 5). Thus, in this mutant, very
little of butyrate-derived portion of monensin A is derived from the
acetate pool and must be generated from some other pathway, such as
isomerization of the valine catabolite isobutyryl-CoA.
|
Effect of crotonic acid and butyric acid on monensin A/monensin B ratios. The increased levels of CCR activity in S. cinnamonensis C730.1/pHL18 did not significantly alter the monensin A/monensin B ratio or increase the intact incorporation of dually labeled acetate into the butyrate-derived position of monensin A, suggesting that some additional factor controlled the concentrations of butyryl-CoA. The possibility that under the growth conditions used the crotonyl-CoA substrate for CCR was limiting was investigated by carrying out fermentations in the presence of crotonic acid and butyric acid. The addition of either crotonic acid or butyric acid to S. cinnamonensis C730.1 led to a significant increase in the monensin A/monensin B ratio (Fig. 4). A similar result was observed with S. cinnamonensis C730.1/pHL18. S. cinnamonensis L1, in contrast, showed an increase in the monensin A/monensin B ratio when grown in the presence of butyric acid but not crotonic acid (Fig. 4). These results demonstrate that the concentration of crotonyl-CoA is a limiting factor in monensin A biosynthesis in the wild-type strain and further verify a physiological role of the cloned S. cinnamonensis ccr gene in converting this crotonyl-CoA to butyryl-CoA.
Effect of CCR on fatty acid profiles. It has previously been shown that exogenously supplied labeled butyric acid can be used intact, presumably as a coenzyme A thioester, as a starter unit for straight-chain fatty acid biosynthesis (26, 27). In addition, butyryl-CoA has recently been shown to be an efficient substrate for the 3-ketoacylsynthase III which is thought to initiate both straight-chain and branched-chain fatty acid biosynthesis in streptomycetes (11). Alterations in the concentration of the butyryl-CoA pool through changes in the levels of CCR activity in S. cinnamonensis were reflected in changes in the monensin A/monensin B ratio. The amount of even-carbon-number straight-chain fatty acids relative to that of other fatty acids might also be predicted to reflect changes in the concentration of the butyryl-CoA pool. The ratios of palmitate to the other fatty acids, however, were the same in fatty acid analyses of S. cinnamonensis C730.1, C730.1/pHL18, and L1.
| |
DISCUSSION |
|---|
|
|
|---|
A number of important macrolide and polyether polyketides, such as tylosin and monensin A, contain ethyl side chains derived from a butyryl-CoA precursor (8, 9). In some cases, analogs with either a methyl or an allyl side chain have also been isolated (6, 9). As these analogs typically exhibit differences in biological activity, it is relevant to understand factors controlling the ratio of the different analogs produced within a fermentation. For S. cinnamonensis, the ratio of the ethyl side chain product monensin A to the methyl side chain product monensin B appears to be dictated by the levels of the carboxylated butyryl-CoA precursor, ethylmalonyl-CoA, relative to those of methylmalonyl-CoA. In this study, it has been demonstrated that factors which affect the concentrations of butyryl-CoA within a fermentation lead to predictable changes in the monensin A/monensin B ratio.
The enzyme CCR, putatively involved in the final step of a pathway
leading to butyryl-CoA from acetyl-CoA, was first identified in
S. collinus (25). Initially, it was suggested
that CCR was responsible for providing butyryl-CoA for fatty acid
biosynthesis. While disruption of the corresponding ccr gene
resulted in a decreased ability to grow on acetate as a sole carbon
source, a fatty acid profile of the mutant demonstrated no increase in
the straight-chain fatty acid palmitate relative to the branched-chain
fatty acids (12). A similar lack of change in fatty
acid profiles was obtained in the current study with S. cinnamonensis L1. Disruption of the ccr gene in
S. cinnamonensis, however, did lead to a significant reduction in the monensin A/monensin B ratio, indicating a
significantly decreased butyryl-CoA concentration. Butyryl-CoA has
recently been shown to be used efficiently in vitro by
-ketoacyl
acyl carrier protein synthase III, the enzyme which initiates fatty acid biosynthesis (11). Furthermore, the exogenous addition of labeled butyrate (4.3 mM) to streptomycetes fermentations leads to
efficient intact incorporation into the straight-chain fatty acid
palmitate (27). The fact that a loss of CCR activity in S. cinnamonensis L1 decreases the monensin A/monensin B
ratio but not the ratio of palmitate to the branched-chain fatty acids may be a result of the differential timing of fatty acid and polyketide biosynthesis during growth. Alternatively, these observations may
indicate that in the absence of exogenously supplied butyrate, acetyl-CoA is the major precursor used to initiate palmitate biosynthesis.
The current study clearly demonstrates that CCR plays a major role in providing butyryl-CoA for monensin A biosynthesis and that the S. cinnamonensis ccr gene, primarily responsible for this enzyme activity, is located within the same sets of homologous genes observed in S. coelicolor and S. collinus (12). In all of these organisms, ccr is located upstream of meaA, another gene required for efficient growth on acetate. In all three organisms, the cloned ccr gene is not clustered with any polyketide biosynthetic genes. Thus, it appears that ccr and meaA are part of an operon involved in primary metabolism and as such may be present in many if not all streptomycetes (a related set of genes also appears to be involved in primary metabolism in Methylobacterium extorquens [7, 21]). Apparent homologs of S. cinnamonensis ccr have been identified in the tylosin (ccr; 79% identity and 85% similarity), coronafacic acid (cfa8; 34% identity and 50% similarity), and niddamycin biosynthetic gene clusters (8, 17, 22) (Fig. 2). All of these polyketides, like monensin A, have an ethyl side chain derived from a butyryl-CoA precursor. It is currently unknown what role these ccr homologs play in providing butyryl-CoA and whether the producing organisms also contain a second copy of ccr clustered with meaA. A ccr homolog making a relatively minor contribution to the production of butyryl-CoA might similarly be located within the monensin biosynthetic gene cluster. Consistent with this possibility are the observations that in S. cinnamonensis L1, residual CCR activity can be detected and dually labeled acetate is still incorporated into the butyrate-derived position of monensin A (albeit at an efficiency markedly lower than that in S. cinnamonensis C730.1).
The ability of S. cinnamonensis L1 to produce some levels of monensin A despite a significant decrease in CCR activity demonstrates that under the fermentation conditions used, another pathway or pathways can contribute to the production of butyryl-CoA. Furthermore, it is evident that in S. cinnamonensis L1, the loss of butyryl-CoA via CCR is not significantly compensated for by an increase in flux through alternate pathways. The most likely alternate pathway for butyryl-CoA formation is isomerization of the valine catabolite isobutyryl-CoA, catalyzed by ICM. Consistent with this hypothesis is the observation that the growth of S. cinnamonensis L1 in a chemically defined medium with valine as a major component results in a mixture of monensins A and B, while almost exclusively monensin B is produced if alternative amino acids, such as isoleucine, are used (14a). The icm gene has recently been identified from S. cinnamonensis (29), and it should be possible to unequivocally demonstrate the role of ICM in monensin A biosynthesis by deletion of the gene in S. cinnamonensis L1.
Based on enzyme assays of cell extracts, S. cinnamonensis C730.1 grown in the monensin production medium exhibits surprisingly high levels of CCR. Accordingly, the amount of monensin A made relative to monensin B in this strain is limited less by CCR activity than by availability of the crotonyl-CoA substrate. Thus, no significant increase in the ratio of monensin A to monensin B is observed with an increase in the levels of CCR in S. cinnamonensis C730.1/pHL18. On the other hand, the addition of crotonic acid to this strain and the wild-type strain but not S. cinnamonensis L1 results in significant increases in the monensin A/monensin B ratio. A similar effect has recently been observed for FK520-producing Streptomyces hygroscopicus var ascomyceticus, where the addition of 5.6 mM crotonic acid reduces the level of a major analog impurity (FK523) from 6.7 to 2.5% (23). Thus, this organism, like S. cinnamonensis, appears to have CCR present at sufficient levels that the availability of the crotonyl-CoA substrate contributes to the FK520/FK523 ratio. Indeed, detectable levels of CCR activity have been observed in this organism, and PCR has been used to identify a 384-bp fragment which encodes a putative CCR with 88% amino acid sequence identity to the S. collinus CCR (19, 23). In contrast, S. erythraea cell extracts contain no clearly detectable CCR activity, and no evidence of a ccr gene in this organism can be found by Southern hybridization with the S. collinus ccr gene as a probe (22). In S. erythraea EAT4, the production of 6-ethylErA (the ethyl analog of erythromycin) is dependent upon either the addition of butyric acid or the expression of the S. collinus ccr gene (22). Thus, in S. erythraea the availability of the butyryl-CoA precursor for polyketide biosynthesis is limited by the levels of the enzyme CCR and not the substrate crotonyl-CoA (despite the fact that this organism is known to contain an ICM for converting the valine catabolite isobutyryl-CoA to butyryl-CoA [27]).
In conclusion, the monensin A/monensin B ratio produced by S. cinnamonensis is dependent upon both the levels of CCR activity and the substrate for this enzyme, crotonyl-CoA. Manipulation of the levels of both of these factors through either genetic approaches or changes in the components of the fermentation medium can be used to alter this ratio in a predictable fashion.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Stewart Campbell at Insmed Pharmaceuticals for the use of a refractive index detector for HPLC analysis of monensin production. Eli Lilly & Company kindly provided S. cinnamonensis C730.1.
Financial support was provided by the National Institutes of Health (grant GM50542).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: ISBDD, Suite 212B, 800 East Leigh St., Richmond, VA 23219. Phone: (804) 828-5679. Fax: (804) 827-3664. E-mail: kareynol{at}hsc.vcu.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, W. Meyers, and D. J. Lipman. 1990. Basic local alignment search tools. J. Mol. Biol. 215:403-410[Medline]. |
| 2. | August, P. R., T. Lang, Y. J. Yoon, S. Ning, R. Muller, T. W. Yu, M. Taylor, D. Hoffman, C. G. Kim, X. Zhang, C. R. Hutchinson, and H. G. Floss. 1998. Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic cluster of Amycolatopsis mediterranei. Chem. Biol. 5:69-79[Medline]. |
| 3. | Beran, M., and J. Zima. 1993. Determination of monensins A and B in the fermentation broth of Streptomyces cinnamonensis by high performance liquid chromotography. Chromatographia 35:206-208. |
| 4. | Bibb, M. J., G. R. Janssen, and J. M. Ward. 1985. Cloning and analysis of the promoter region of the erythromycin gene (ermE) of Streptomyces erythraeus. Gene 38:215-226[Medline]. |
| 5. | Bierman, M., R. Logan, K. O'Brien, E. T. Seno, R. N. Rao, and B. E. Schoner. 1992. Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene 116:43-49[Medline]. |
| 6. | Byrne, K. M., A. Shafiee, J. B. Nielsen, B. Arison, R. L. Monaghan, and L. Kaplan. 1993. The biosynthesis and enzymology of an immunosuppressant, immunomycin, produced by Streptomyces hygroscopicus var. ascomyceticus. Dev. Ind. Microbiol. 32:29-44. |
| 7. |
Chistoserdova, L. V., and M. E. Lidstrom.
1996.
Molecular characterization of a chromosomal region involved in the oxidation of acetyl-CoA to glyoxylate in the isocitrate-lyase-negative methylotroph Methylobacterium extorquens AM1.
Microbiology
142:1459-1468 |
| 8. | Gandecha, A. R., S. L. Large, and E. Cundliffe. 1997. Analysis of four tylosin biosynthetic genes from the tylM region of the Streptomyces fradiae genome. Gene 184:197-203[Medline]. |
| 9. | Gorman, M., J. W. Chamberlin, and R. L. Hamill. 1967. Monensin, a new biologically active compound. V. Compounds related to monensin. Antimicrob. Agents Chemother. 7:363-367[Medline]. |
| 10. |
Guilfoile, P. G., and C. R. Hutchinson.
1992.
The Streptomyces glaucescens TcmR protein represses transcription of the divergently oriented tcmR and tcmA genes by binding to an intergenic operator region.
J. Bacteriol.
174:3659-3666 |
| 11. |
Han, L.,
S. Lobo, and K. A. Reynolds.
1998.
Characterization of -ketoacyl acyl carrier protein synthase III from Streptomyces glaucescens: its role in the initiation of fatty acid biosynthesis.
J. Bacteriol.
180:4481-4486 |
| 12. |
Han, L., and K. A. Reynolds.
1997.
A novel alternate anaplerotic pathway to the glyoxylate cycle in streptomycetes.
J. Bacteriol.
179:5157-5164 |
| 13. | Hopwood, D. A., M. J. Bibb, K. F. Chater, T. Kieser, C. J. Bruton, H. M. Kieser, D. J. Lydiate, C. P. Smith, J. M. Smith, J. M. Ward, and H. S. Schrempf. 1985. Genetic manipulation of streptomycetes: a laboratory manual. John Innes Institute, Norwich, United Kingdom |
| 14. |
Kakavas, S. J.,
L. Katz, and D. Stassi.
1997.
Identification and characterization of the niddamycin polyketide synthase genes from Streptomyces caelestis.
J. Bacteriol.
179:7515-7522 |
| 14a. | Liu, H., and K. A. Reynolds. Unpublished results. |
| 15. | Lydiate, D. J., A. M. Ashby, D. J. Henderson, H. M. Kieser, and D. A. Hopwood. 1989. Physical and genetic characterization of chromosomal copies of the Streptomyces coelicolor minicircle. J. Gen. Microbiol. 135:941-955. |
| 16. | MacNeil, D. J., K. M. Gewain, C. L. Ruby, G. Dezeny, P. H. Gibbons, and T. MacNeil. 1992. Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel intergration vector. Gene 111:61-68[Medline]. |
| 17. |
Rangaswamy, V.,
R. Mitchell,
M. Ullrich, and C. Bender.
1998.
Analysis of genes involved in biosynthesis of coronafacic acid, the polyketide component of the phytotoxin coronatine.
J. Bacteriol.
180:3330-3338 |
| 18. | Reynolds, K., D. O'Hagan, D. Gani, and J. A. Robinson. 1988. Butyrate metabolism in streptomycetes. Characterization of a vicinal interchange rearrangement linking isobutyrate and butyrate in Streptomyces cinnamonensis. J. Chem. Soc. Perkin Trans. 1 1988:3195-3207. |
| 19. | Reynolds, K. A., and A. L. Demain. 1997. Rapamycin, FK506, and ascomycin-related compounds, p. 497-521. In W. R. Strohl (ed.), Biotechnology of antibiotics, 2nd ed. Marcel Dekker, Inc., New York, N.Y |
| 20. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y |
| 21. |
Smith, L. M.,
W. G. Meijer,
L. Dijkhuizen, and P. Goodwin.
1996.
A protein having similarity with methylmalonyl CoA mutase is required for assimilation of methanol and ethanol by Methylobacterium extorquens AM1.
Microbiology
142:657-684 |
| 22. |
Stassi, D. L.,
S. J. Kakavas,
K. A. Reynolds,
G. Gunawardana,
S. Swanson,
D. Zeidner,
M. Jackson,
H. Liu,
A. Buko, and L. Katz.
1998.
Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering.
Proc. Natl. Acad. Sci. USA
95:7305-7309 |
| 23. | Sun, W.-S., P. Salmon, J. Wilson, and N. Connors. 1998. Crotonic acid directed biosynthesis of the immunosuppressants produced by Streptomyces hygroscopicus var. ascomyceticus. J. Ferment. Bioeng. 86:261-265. |
| 24. |
Tang, L.,
Y. X. Zhang, and C. R. Hutchinson.
1994.
Amino acid catabolism and antibiotic synthesis: valine is a source of precursors for macrolide biosynthesis in Streptomyces ambofaciens and Streptomyces fradiae.
J. Bacteriol.
176:6107-6119 |
| 25. | Wallace, K. K., Z. Bao, H. Dai, R. Digate, G. Schuler, M. K. Speedie, and K. A. Reynolds. 1995. Purification of crotonyl CoA reductase from Streptomyces collinus and cloning, sequencing and expression of the corresponding gene in Escherichia coli. Eur. J. Biochem. 233:954-962[Medline]. |
| 26. |
Wallace, K. K.,
S. Lobo,
L. Han,
H. A. I. McArthur, and K. A. Reynolds.
1997.
In vivo and in vitro effect of thiolactomycin on fatty acid biosynthesis in Streptomyces collinus.
J. Bacteriol.
179:3884-3891 |
| 27. | Wallace, K. K., B. Zhao, H. A. I. McArthur, and K. A. Reynolds. 1995. In vivo analysis of straight-chain and branched-chain fatty acid biosynthesis in three actinomycetes. FEMS Microbiol. Lett. 131:227-234[Medline]. |
| 28. |
Xue, Y.,
L. Zhao,
H.-W. Liu, and D. H. Sherman.
1998.
A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity.
Proc. Natl. Acad. Sci. USA
95:12111-12116 |
| 29. |
Zerbe-Burkhardt, K.,
A. Ratnatilleke,
N. Philippon,
A. Birch,
A. Leiser,
J. W. Vrijbloed,
D. Hess,
P. Hunziker, and J. A. Robinson.
1998.
Cloning, sequencing, expression, and insertional inactivation of the gene for the large subunit of the coenzyme B12-dependent isobutyryl-CoA mutase from Streptomyces cinnamonensis.
J. Biol. Chem.
273:6508-6517 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»